Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine
Deanna L. Kelly(University of Maryland, Baltimore), Robert R. Conley(University of Maryland, Baltimore), Quynh Van-Duong, Raymond C. Love(FrontLine Service), Julie Kreyenbuhl(University of Maryland, Baltimore)
Cited by 14
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
|Schizophrenia Bulletin|2009|501